SCHEMBL4669384

SCHEMBL4669384

CCOC(=O)C1=C(C)N=c2s/c(=C/c3ccc(O)cc3)c(=O)n2C1c1ccc(Oc2ccc(Cl)cc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DUSP3 P51452 8/20 0.78
PTPN22 Q9Y2R2 7/20 0.78
MEN1 O00255 7/20 0.78
KMT2A Q03164 7/20 0.78
PTPN7 P35236 6/20 0.78
POLB P06746 4/20 0.78
PTPN12 Q05209 4/20 0.78
DNMT1 P26358 3/20 0.78
BLM P54132 2/20 0.78
CACNA1B Q00975 2/20 0.78
APBA1 Q02410 2/20 0.78
L3MBTL1 Q9Y468 2/20 0.78
CSNK2A2 P19784 2/20 0.77
CSNK2B P67870 2/20 0.77
CSNK2A1 P68400 2/20 0.77
CDC25B P30305 1/20 0.68
PSMD14 O00487 1/20 0.65
DUSP6 Q16828 2/20 0.65
PTPN5 P54829 2/20 0.65
USP2 O75604 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4669385 1.00 DUSP3 (0.78) DUSP3PTPN22MEN1KMT2APTPN7
SCHEMBL14001018 1.00 DUSP3 (0.78) DUSP3PTPN22MEN1KMT2APTPN7
SCHEMBL14001421 0.91 PTPN22 (0.85) DUSP3PTPN22MEN1KMT2APTPN7
SCHEMBL13980786 0.91 DUSP3 (0.65) DUSP3PTPN22MEN1KMT2APTPN7
SCHEMBL13855916 0.90 PTPN22 (0.83) DUSP3PTPN22MEN1KMT2APTPN7
SCHEMBL13855923 0.89 MEN1 (0.79) DUSP3PTPN22MEN1KMT2APTPN7
SCHEMBL4669021 0.88 MEN1 (1.00) DUSP3PTPN22MEN1KMT2APTPN7
SCHEMBL31541578 0.88 MEN1 (1.00) DUSP3PTPN22MEN1KMT2APTPN7
SCHEMBL4669023 0.88 MEN1 (1.00) DUSP3PTPN22MEN1KMT2APTPN7
SCHEMBL14001087 0.87 CDC25B (0.74) DUSP3PTPN22MEN1KMT2APTPN7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2000140-A1 Use of derivatives of 3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5H-imidazolo[3,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-12-10 EP disclosed